跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
POMALIDOMIDE SANDOZ pomalidomide 3 mg capsule blister pack - TGA Drug Approval Details
Approvals
/
TGA
/
POMALIDOMIDE SANDOZ pomalidomide 3 mg capsule blister pack
Approved
STANDARD
POMALIDOMIDE SANDOZ pomalidomide 3 mg capsule blister pack
Sandoz Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
7d1abf2a72ca472e
Company
Sandoz Pty Ltd
Type
Standard
Approval Details
Approval Id
7d1abf2a72ca472e
Product Name
POMALIDOMIDE SANDOZ pomalidomide 3 mg capsule blister pack
Artg Id
352571
Artg Name
POMALIDOMIDE SANDOZ pomalidomide 3 mg capsule blister pack
Sponsor
Sandoz Pty Ltd
Company Detail Path
/organization/sandoz-pty-ltd
Artg Date
2022-06-02
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2022-CMI-01980-1
Product Information
http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2022-PI-01572-1
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
7d1abf2a72ca472e
Type
Standard
Back to TGA Approvals